UPDATE 1-Teva says Actavis deal to close by April as profit falls

* Sees Q1 adjusted EPS $1.32-$1.36, revenue $4.7-$4.9 bln (Adds Teva comments, details from conference call)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.